The NCPA National Legislation Committee and the NCPA State Government Affairs Committee meet separately today to discuss recent legislative events and to come up with a legislative action plan for 2024. This has been a transformative year already for pharmacy with actions at the state level and the federal level that point the way to a bright future. This past June, the Senate heard about the NCPA-backed legislation called Protect Patient Access to Pharmacies Act. In July, the FTC walked back its previous statements that protected PBMs, leaving the middlemen with barely a fig leaf to hide behind. And before it went on summer break, the Senate Finance Committee advanced the Modernizing and Ensuring PBM Accountability Act to the full Senate by a 26-1 vote. This package contained several NCPA priorities including a cost-plus reimbursement floor in all state Medicaid managed care programs and standardized quality metrics and mandated claim-level reporting for all Medicare Part D plans. Less than six weeks ago, members around the country participated in NCPA’s Month of Action by inviting legislators to their home turf — their pharmacies — to talk about PBM reform, reimbursements, the challenges of staying independent, and what 2024 will hold. Want to stay in the loop on NCPA’s advocacy efforts at every level? You can!
NCPA
